The FDA ( Food and Drug Administration ) approved the drug on Nov. 20 for patients with myeloma who have received at least one previous therapy. In the trial, ...

" Researchers and clinicians can use it to reduce the expression of the target gene in a single or limited numbers of cell types or tissues, thereby reducing ...

With this approval, Amitiza becomes the only FDA-approved medical treatment for irritable bowel syndrome with constipation available in the United States.

The findings follow results from previous, less rigorous studies that found a significant number of the population could be suffering from some form of Internet ...

The University of Michigan study provides the first direct evidence that the brain's own pain-fighting chemicals, called endorphins, play a role in the ...

The body's overwhelming genetic defense, which has implications for the survival of patients who are severely burned or injured, was revealed in a sweeping ...

A research from Wake Forest University School of Medicine suggests novel treatment targets for the most common form of childhood epilepsy – with the ...

In addition, they tested a genetically engineered virus to deliver two proteins directly to the brain. The findings are reported in the journal Cancer Research.

The Phase 2 clinical trial has also found that AZD2171 treatment can alleviate brain swelling ( edema ), a debilitating symptom in many brain cancer patients ...

Researchers at the Duke University Medical Center have pinpointed circuitry in the brains of monkeys that assesses the level of risk in a given action.